In July 2013, the Federal Trade Commission (FTC) officially fined the debt collection agency Expert Global Solutions, based out of Plano, Texas, for using tactics that were a violation consumer rights.These tactics included calling consumers multiple times a day, calling at very early or very late times, and calling consumers at work.The fines total $3.2 million dollars, the largest debt collector fine ever issued.
Expert Global Solutions is the world’s largest debt collector.They have over 32,000 employees worldwide and own a number of subsidiaries, including branches in India, Canada, and the Philippines.The company reported earnings of over $1.2 billion in 2011 as reported on the FTC’s website.
The Charges against Expert Global Solutions
The FTC charged Expert Global Solutions with violating the FTC Act and the Fair Debt Collection Practices Act in several ways.They continued to call consumers, sometimes four or five times a day, even after being told not to call or being told that the debt in question had been paid off.Rather than check the records to verify that the debt had been paid off or that the consumer in question didn’t even owe the debt, they continued to call.They also violated these acts by calling the consumers’ work places and leaving messages with third parties that included the consumer’s name and the fact that they owed a debt.
The Outcome of the Review
In addition to the $3.2 million dollars the FTC charged Expert Global Solutions with, the company was also given several orders to ensure that they would no longer engage in any violation of consumer rights.These included immediately ceasing to harass consumers outside of standard calling hours and no longer calling multiple times a day.If a consumer disputed a debt or said the debt was paid, no further calls could be made until Expert Global Solutions verifies the information.They may not leave voice mails or messages with third parties containing any personal information or the fact that the consumer owes a debt.To ensure that no further violations are made, the company was ordered to begin recording at least three-fourths of all calls starting one year after the order was given.
What Does This Mean for You?
If you have a debt that Expert Global Solutions was trying to collect, it means you won’t be harassed by them any longer.It also means other debt collectors will be more cautious when using harassing methods to collect debts.Now that they know that the FTC is serious about leveling debt collector fines for those who violate consumer rights and harass people, they will be less likely to engage in such behavior themselves.
Debt Collection Agencies and Scams
While Expert Global Solutions is a legitimate debt collector that was using harassing methods to collect debts, there are some fake debt collectors that make the same type of calls.These credit scams often begin by telling the consumer that they owe a debt and, when the consumer denies it, the caller asks for the consumer’s name and other personal information so they can “verify” that the person doesn’t owe the debt.They then use this information to get credit cards or loans in the person’s name.If you’ve been called about a debt you don’t owe, do not give out any personal information and immediately check your credit report to make certain no one has attempted to get a loan or credit card in your name.Always remember to do a credit check at least once a year if not more often just to make sure no one has stolen your identity.Debt collectors calling is often one of the first signs that you have been the victim of a credit scam.
For stock market investors, 2013 has been a great year so far. On November 6th, the Dow Jones Industrial Average hit yet another record high, closing at 15746.88. This is a rise of 20.17% since the beginning of the year. Small-cap stocks have done even better, with the Dow Jones U.S. Small-Cap Total Stock Market Index up 30.53% in the year to date. There have been a few shaky moments along the way, particularly when the Fed made noises about tapering off quantitative easing, but there is no doubt we are in a bull market at the moment.
However, there has been a lot of speculation that the stock market is in fact entering a bubble, and that this may be similar to the housing bubble that led to the financial crisis in 2008 – as well as the dotcom bubble that came to an abrupt end in 2000. The putative culprit is quantitative easing – the nearly $4 trillion that the Fed has pumped into the US economy through asset purchases since 2008. While some economists believe that this quantitative easing has had an overall positive effect on the economy, there are also a large number of financial experts who believe it has had no effect or has been detrimental – for example, see this Betting Against Bernanke article in Forbes.
The theory behind why quantitative easing drives up stock prices is relatively straightforward. There are two main effects. First of all, quantitative easing involves buying long-term bonds, which in turn drives down the interest rates on these. The reason for this is that when there is a strong demand for bonds – which is exactly what quantitative easing artificially creates – bond issuers do not have to offer such high interest rates in order to attract investors. This in turn means that bonds are less attractive to non-governmental investors, and so they turn to stocks instead – driving up the price.
The second reason is that quantitative easing makes more capital available to businesses at lower rates. This allows them to swap high-cost debt for low-cost debt and buy back stock – improving their earnings per share and driving up the value of the remaining stock. In principle, they can also use the money to grow their business organically and make acquisitions, again driving up the stock price because the fundamental value has increased.
So, with everybody still wondering when the Fed will start to taper quantitative easing, should we be worried about the stock market imploding? There are certainly reasons to be cautious – for example, the overall P/E ratio on the Dow Jones Industrial Average has risen from 14.16 to 17.66 in the last year, with a proportionately smaller increase in the S&P 500 and a somewhat larger one on the NASDAQ 100. However, the current DJIA P/E ratio is not completely out of line with historical values – for instance, it wandered between 15 and 20 for most of the 1960s, and was well above 20 prior to the financial crisis in 2008. In other words, one of the reasons that stock prices are so high is that companies are turning in record profits. That’s the way stock markets are supposed to work.
However, just because companies are making more money than ever before does not mean that they are actually healthy. What about all that quantitative easing money that has flowed into them? Surely this has distorted their balance sheets? Perhaps not. Robert D. Auerback, formerly an economist involved in oversight of the Federal Reserve, recently pointed out that there has been an explosion in private bank reserves since the Fed started to pour money into the economy in August, 2008. Auerbach estimates that 81.5% of all the quantitative easing monies are sitting on the balance sheets of banks, rather than being in general circulation. That means that while the Fed continues to pump $85 billion a month into the economy, a little less than $16 billion is actually hitting the street. While that may have some effect on the profitability of firms, it certainly isn’t responsible for the jump in corporate profits that we have seen.
NHUR (Northumberland Resources) is running a very bullish reversal trend and closed another session with trading ending up 3% at $0.106 indicating a very bullish reversal trend is in play. Earlier Northumberland Resources was hammered heavy due to falling oil prices. NHUR steadied itself and is now rising again.
However, there’s a little sting here; our investigations reveal that NHUR is definitely in the oversold territory. This week and next oil prices are expected to make a recovery and we should see the NHUR stock reach for the stars!
Our Stock Penny Picks experts point out that Northumberland Resources is a conservative, well focused company that is averse to taking unnecessary risks in the field of oil and gas exploration. It has a focused strategy of building a substantial portfolio in oil and gas assets.
The conservative team at Northumberland will only exploit projects that can deliver immediate cash follows with minimal exposure to risk. Their strength obviously lies in the lab test results and a level-headed approach to business; two points that will see them roar to success. In fact, their CEO recently said “We are building a future of sustained prosperity for our shareholders through our exceptional oil and gas project portfolio and a dedicated management team.”
Wind Works Power Corp WWPW – 150 Megawatt Thunder!
Wind Works Power Corp. Is on a new track – that of building viable and long-term sustainable relationships with large, financially stable energy companies. Needless to say, this can only spell financial success to the Wind Works Power Corp. bottom line. Long term agreements and contracts also enable future planning and growth strategies something that investors love.
Wind Works Power Corp. recently secured two important permits for their 150 MW Thunder Spirit power project in North Dakota. This coming on top of the Interconnect Agreement will boost the company prospects. All they now need to add is Power Purchase Agreement(s) and this is where the long term agreements will come in.
E-Waste Systems Inc (OTCMKTS:EWSI)
In the 4-month period of June to September, E-Waste Systems Inc registered an impressive 60% increase quarter-over-quarter to reach $4.5 million in revenues. People in the know gleefully claim that the next quarter results will be even more impressive. In fact, they claim that the company is targeting revenues to the tune of $6 million which means that total revenues for this year would probably cross $12 million.
Based on shares traded, a couple of Bullish Penny Stock might be worth keeping an eye on. These are Global Earth Energy Inc (OTCMKTS:GLER) and Life Stem Genetics Inc (OTCBB:LIFS).
Our pick of highly rated stocks include:
BIIB BIOGEN IDEC INC A
AMGN AMGEN INC A
GILD GILEAD SCIENCES INC A-
UTHR UNITED THERAPEUTICS CORP A-
GENT GENTIUM SPA –ADR B+
MYGN MYRIAD GENETICS INC B
LGND LIGAND PHARMACEUTICAL INC B
PDLI PDL BIOPHARMA INC B
CBPO CHINA BIOLOGIC PRODUCTS INC B
EBS EMERGENT BIOSOLUTIONS INC B
“Only buy something that you’d be perfectly happy to hold if the market shut down for 10 years.”
- Warren Buffett, the world's greatest investor
No one would dispute the fact that Warren Buffett is THE most successful and influential investor and investment guru of our times. No one would be foolish enough to not listen when he's doling out investment advice. No one would make the mistake of overlooking or ignoring his investment tips and suggestions. Sure, you already know that. But do you that he is an avid real estate investor too? Well, if he's doing it, you should probably be doing the same, right? So without wasting any more time, let's get down to business and understand more about real estate as a lucrative investment option in today's uncertain economic conditions.
(Image courtesy: http://theretiringboomer.ca/wp-content/uploads/2013/06/photodune-4767239-where-to-invest-concept-xs-624x448.jpg)
To gain the maximum profit out of real estate investment, you need to be in it for the long haul. Think long-term investing, think high returns. Show patience and you'll be rewarded. The fact that a house in itself is considered as an asset in the financial world must mean something, right? So you must be prepared to hold on to it and wait for the right time to sell it off.
It is important to remember that to invest in real estate, you need to have that kind of capital. Buying and selling homes isn't a simple process, it requires time and patience on the part of all the parties involved. Are you ready to commit so much of your time, money and energy into a long-term investment? Think it through thoroughly and only once you're sure of this option, charge ahead in full speed.
(Image courtesy: http://www.bestalbuquerquenewhomes.com/waylon-chavez/wp-content/uploads/2012/02/investments1.jpg)
Real estate is considered a good source for generating continuous inflow of money. If leased out on rent, it can become a great source of generating a good amount of monthly income, based on the size of the property, number of rooms, number of baths, amenities offered, furnishings, etc. If you've taken out a loan to buy an apartment and are trying to pay it off, you could simply divert the rent earned toward paying the EMIs. You need to price your rent accordingly to be able to cover up all the costs.
Whether it is an apartment or land that you have invested in, it's value might continue to rise with time. Even if price fluctuations do take place, they won't be much. However, one needs to exercise caution as after all it is your hard earned money that you're putting in. While investing in land, you should thoroughly examine the deed for the same. Make sure you educate yourself about the upcoming construction around your land to be able to decipher its future value proposition. At times, this aspect can be highly influential in the appreciation or depreciation of land prices.
A great way of directing your hard earned money optimally while buying or selling real estate is by ruling out the involvement of an estate agent by carrying out your deals on your own on an online platform i.e. on a website dedicated to helping you connect directly with interested buyers/sellers. That way you can save on real estate commissions and put all the capital to good use toward your investment. Do think about that seriously.
(Image courtesy: http://www.1031taxinfo.com/images/site_graphics/invest_in_real_estate.jpg)
Be Wise about Your Investment
It never hurts to think hard before investing, especially when your precious money is at stake. Being realistic and practical about your investments will go a long way in taking you in the right direction.
Buying residential property: If you're buying real estate for the first time, it makes sense to stick to familiar territory and invest in residential real estate since you already have an experience of how these properties are managed.
Bust those myths: Do not base your investment decision on mere speculation. If you're buying real estate with hopes and expectations that it will appreciate in the near future, you might be in for a rude surprise. Base your decision on facts and solid reasons. That way even if the real estate markets falls, you wouldn't feel left out in the cold about it. Do not believe dangerous myths like real estate value HAS TO go up all the time.
Do your research: Do not believe everything that your agent or builder tells you about their offering. Ultimately, they have to make a sale but you need to be smart enough to know what the reality might be. Take some time out to do your own research about the builder's background and the agent's credibility. You can take it one step further by investigating the ongoing prices in your locality of interest and the amenities being offered by other builders. No wonder they say Knowledge is Power!
Source(s) of funds: Don't kid yourself by biting off more than what you can chew. Be realistic about your budget, how you will arrange for the loan, and plan wisely as to how you would be paying it off. Keep in mind the market conditions and accordingly make your plans.
(Image courtesy: http://www.trbimg.com/img-5283db98/turbine/la-fi-mo-most-distrust-real-estate-agents-2013-002/600)
Real Estate versus Gold
If you find yourself puzzled between real estate and gold as investment options, you're not alone.
Gold has always been in high demand all over the world with not many alternatives available to it. However, you have a long time to go before you can actually make money from this investment, as it limits the possibility of gaining instant returns from it.
Real estate properties are currently available at lower rates as compared to the rates in 2010 and investing now would probably be considered as correct timing. As the market picks up, which is expected to happen gradually, you can expect some high returns on this valuable investment.
(Image courtesy: http://realwealthnetwork.com/rwn/wp-content/uploads/2011/06/house_gold_puzzle1.jpg)
There are many reasons why you should be investing in real estate and there always will be. From the investor's end, you just need to be at the right place at the right time. Study the pros and cons of any investment you make and you'll surely find yourself on the right track to multiplying your money.
Dendreon Corp. (DNDN), founded in 1992 and taken public in 2000, with a share value just about one-third of its 52 week high, recently announced it was potentially for sale. The immediate question springing to my mind was why would anyone buy Dendreon? Frankly, I never understood why anyone would want to own the stock, much less the company!
One of the poorest performing stocks this year and frankly for most of its corporate life, Dendreon hardly seems to fit the mold of a realistic acquisition target. My day job is in the insurance business and while it requires a certain level of business acumen, I don’t pretend to be an expert on mergers and acquisitions.
Correct me if I’m wrong, but I have always thought that there were two basic scenarios driving an acquisition:
1) One company covets another company because it is doing well, has desirable intellectual property, etc.
2) One company sees an opportunity to buy a struggling company for a bargain price
While Dendreon meets the definition of struggling, I am having a difficult time getting my head around the notion of Dendreon at a bargain price.
First of all revenues have been on the decline since peaking in June 2012 and earnings per share have never emerged from negative territory. Its flagship treatment for late stage prostate cancer, PROVENGE is competing in a lackluster way against far less expensive rival treatments from Medivation’s (MDVN) Xtandi and Johnson and Johnson’s (JNJ) Zytiga. In short, Dendreon has no compelling intellectual property and sports an income statement that would make any analyst weep. I recognize, as we all do, that biotech stocks are notorious for shabby balance sheets, income and cash flow statements. Most generally run into buckets of red ink until they make that breakthrough treatment a reality.
Dendreon accomplished that, but the red ink continued to flow, in part, due to management missteps in marketing and its inability to adequately curb expenses. Then the apocalyptic forces of competing treatments ultimately doomed Dendreon to its present “for sale” fate.
Unfortunately for Dendreon and its shareholders, any potential buyer would be acquiring substantially greater liabilities than assets—in my view, this is not a scenario that will foster an acquisition.
Analyst thinking, surprisingly, is all over the map. Some are in my camp, believing the company can’t be sold because of its financial position. Another sees Provenge as a viable asset, meaning acquisition is a possibility and yet others prophesy that no buyer will emerge and Dendreon is doomed to bankruptcy.
Dendreon shares did bounce on the news of a potential sale, but that’s typical for the market and not really indicative of anything tangible. I look for even that tiny bubble to burst before Dendreon announces third quarter results on November 12th. After the figures which emerge are dissected, we will see a more definitive direction for the stock price. I’m betting it s down and with roughly 60 million shares short, a host of others must be placing the same bet.
Of course, if a buyer pops up or Dendreon is able to make a stunning announcement when it reports third quarter results November 12th, everyone could be caught with their shorts down.
All kidding aside, Dendreon is facing a crucible, to put it mildly. Dendreon has promised for more than four quarters now, that it could achieve positive cash flow with a $100 million net revenue quarter. That promise has never been realized and it's unclear if Dendreon would be able to achieve a $100 million quarter in 2014 if should it survive.
Cash and cash equivalents have contracted to just over $280 million from $647 million two short years ago. This is likely to drop to about $250 million when we get the Q3 numbers. Debt will very likely approach the $600 million mark. Since the beginning of 2013, Dendreon’s equity shifted from a positive $35 million to a negative $100 million.
For a prospective buyer, this amounts to buying a house for $500,000 and assuming a first mortgage of $600,000 and a second mortgage of $100,000. Why would you do that?
One thing is certain, absent a deal, and very quickly I might add, Dendreon will need another capital infusion. Dendreon unquestionably has a loyal following of shareholders and many are unbelievably defensive of the company and convinced of its ultimate success.
After 21 years chasing the brass ring it might be time for Dendreon to get off the carousel. Another round of share offerings may be met with more skepticism than takers. Maybe Dendreon could bring some cash in the door by invoice financing with a company like CBAC Funding ... just kidding. In any event, the future of Dendreon will become clearer on November 12th and I for one, am quite content to sit on the sidelines and see how all this will play out.
The penny stocks are the affordable stocks that can be easily traded with the limited budget as well. The investors are getting diverted towards the penny stocks due to the smaller investment and better returns offered in very short time. The paid advisory portals are now available for the investors who want sure shot results from their investments. These portals may offer penny stock pickson daily basis so as to let their clients get most from their money. These hot penny stocks may give quicker results but there are certain important considerations as well to make the investments always work in the positive direction.
Quick tips for trading
I.Invest in 5 stocks at a time so as to cut the risk. If one stock goes down then you at least have four other in the upward moment to nullify the loss. The chances are very slim that all five go downwards at the same time.
II.The hot penny stocks recommended by the experts may be purchased when hot else it will lose its value. Don’t go after the stock once it has moved ahead as it will turn out to a big loss.
III.Lower profit percentage in case of the penny stocks may work well in the long run as you keep on rotating the stock. So, don’t expect high returns at one go.
IV.Penny stocks may require quick selling and hence don’t keep these stocks for long.
Go ahead and use these tips to double your investments with these hot penny stocks.
Why are more and more companies with their head offices in UK registering their companies and corporations in BVI? Company incorporation in BVI [British Virgin Islands] is an extremely good idea for all those businessmen who are farsighted, and who intend to expand their operations and company overseas in the future. But as at the moment, their operations are limited to those in the UK, registering your company and making it into an offshore company means that you do not need to pay taxes in the country of registration.
That is why a number of UK-based companies are being registered in Bermuda, Singapore, Hong Kong, BVI and other countries with a long time economic, financial and business relationship with the UK.
There is an advantage of incorporating your company and registering it in the BVI, apart from not paying any taxes. You can have directors as well as shareholders who are BVI citizens. You can also hold meetings there in the islands. But you cannot buy land there to set up your offices. You may open up a branch of your company in a rented building. Also, you cannot do any direct negotiation and transaction related to the buying and selling of land with BVI citizens.
The BVI encourages investors from the UK and the US, so there is no limit to the amount of money that you can invest here. Also, the incorporation process is streamlined – all you have to do is fill in the form or you may get a firm to handle the paperwork for you. You will need to have documentary proof in the shape of a British passport to show that you are a British citizen. You will also have to show some utility bills to show that you live in the UK.
With your company’s Certificate of Incorporation – to show that you are a genuine and bona fide company – Company’s Memoranda, bylaws, also known as – Article s of Association – contact details, bank statements, credit card and/or profit and loss statements given to the firm, they are going to help in the incorporation of your company. You will also need a list of your directors and shareholders and Company Seal which has been registered, when you obtained the Certificate of Incorporation. This last can be obtained for you by a good company aiding in the company incorporation of your business in the BVI.
So now that you know how easy and how sensible it is to incorporate your company in the BVI, look for firms giving you their professional help in doing this.
November 27,2013 : Bharat Book Bureau presents the new report, on 'Healthcare Analytics & Medical Analytics Market' Healthcare organizations have large amounts of data but often do not have the tools to bring the data together for useful business information and planning. Healthcare analytics is the systematic use of data and related business insights developed through applied analytical disciplines such as, statistical, contextual, quantitative, predictive, cognitive, other including emerging model to drive fact-based decision making for planning, management, measurement and learning. Analytics may be descriptive, predictive or prescriptive.
Healthcare analytics involves application of statistical tools and techniques to healthcare-related data in order to study past situations such as operational performance or clinical outcomes to improve the quality and efficiency of clinical and business processes and performance.
The healthcare analytics market is showing a double-digit growth due to supportive elements such as digitization of world commerce, the emergence of big data and the advance of analytical technologies. Healthcare organizations can differentiate themselves through data analytics. Factors such as, federal healthcare mandates, wide scope of predictive analytics and improvements in the financial and operative function are driving the installation of healthcare data analysis in hospitals. While, the major concerns of this market are the security of data, privacy of individual patients and lack of manpower with cross-functional analytical skills. The healthcare analytics market is estimated to be $3.7 billion in 2012 and is growing at a rate of 23.7% from 2012 to 2017 to reach $ 10.8 billion.
Healthcare payers as well as the providers are leading the users of health care analytics for a range of functions from suggesting the most accurate diagnoses, cost reduction, fraud prevention, revenue generation, service improvement to real-time view of the business. The major driver for business analytics is the return on Investments (ROI), with a median of five years, from 10.0% to 1,000.0%.
For more information kindly visit : http://www.bharatbook.com/healthcare-market-research-reports/healthcare-analytics-medical-analytics-market-predictive-modeling-clinical-analytics-financial-analytics-others-trends-global-forecasts-to-2017.html
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
In case the reports don’t match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.
Contact us at :
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
For live chat : http://bit.ly/19m3TU4
Follow us on twitter: https://twitter.com/researchbook
Follow us on linkedin : http://www.linkedin.com/company/bharat-book-bureau
Our Blog : http://blog.bharatbook.com/
Biotechnology company Northwest Biotherapeutics (“NW Bio”) announced its vaccine, DCVax, was featured on both Fox News and Fox Business News on Nov. 7, 2013.
Dr. Marc Siegel, a clinical associate professor at NYU’s Langone Medical Center, hosted the segment. He described DCVax as a potentially life-extending treatment for all solid tumor cancers, due to its use of biomarkers from a patient’s own tumor cells to activate the person’s immune system to fight cancer within the body.
The process begins with surgical removal of a patient’s tumor, as described by Dr. Lee Tessler, who is participating in a current late-stage Phase III trial of the DCVax immune therapy for brain cancer at the Long Island Brain Tumor Center. The patient’s immune cells are then harvested and exposed, in a laboratory setting, to the biomarkers taken from the patient’s tumor. These conditioned immune cells are then injected back into the patient through a simple under-the-skin injection in the upper arm, similar to a flu shot. These “educated” immune cells then mobilize the patient’s immune system to fight any tumor cells that bear the same biomarkers throughout the body.
In preliminary trials, according to Dr. Siegel, some patients with glioblastoma multiforme (GBM), which is the most common and aggressive form of brain cancer, have seen survival times that are more than double what would be expected under the current standard of care, which consists of surgical removal of the tumor, radiation and chemotherapy. The final stage of DCVax clinical trials for GBM (Phase III) is being conducted at more than 50 sites throughout the United States and Europe.
“Each cancer vaccine is personalized, and it takes just eight days to produce enough for three to five years’ worth of treatment,” said Dr. Siegel. “It’s more cost-effective than older cancer vaccines, and the side effects are minimal versus standard treatments.”
The prognosis for brain cancer patients receiving standard of care has not significantly changed in decades, but DCVax has the potential to substantially improve and extend the lives of cancer patients – both operable and inoperable – without the toxic side effects associated with current treatments.
The Fox segments can be viewed at http://video.foxnews.com/v/2814859046001/could-our-own-bodies-hold-the-key-to-the-curing-cancer/?playlist_id=930909757001.
For more information about NW Bio, visit www.nwbio.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
In 2013 there are 33.5 million people playing fantasy sports in the United States alone, according to Fantasy Sports Trade Association. That’s a huge amount of people – representing the equivalent of the population in Canada, which happens to be home base for digital entertainment company Intelimax Media.
Intelimax Media is well aware of the lucrative fantasy sports market and the opportunities available through the advancement of technologies and growing number of participants. The company focuses on fantasy sports for the web, social media, and land based-endeavors through its proprietary platform, DraftTeam.com.
DraftTeam.com is a fantasy sports platform that allows players to engage in daily and weekly sports contests rather than over a complete season. The company offers fantasy leagues in football, baseball, hockey, and basketball, with more sports options in the future.
Users can access the platform via pc, tablet and mobile, or any device with an Internet connection, and receive real-time updates on the status of their teams.
Intelimax also offers a white label software solution for businesses looking to enter this huge vertical, allowing for co-mingling of traffic from many websites, providing instant liquidity for brands just getting started, and reducing critical mass challenge many upstarts face.
The fantasy sports industry is estimated to be worth more than $5 billion annually. Intelimax has positioned itself to capitalize on this booming opportunity by leveraging a business model that allows for multiple revenue streams and constant evolution.
For more information, visit www.intelimax.com
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net